Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months

Documenti analoghi

• Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter
  di: Panagiotis Pavlou, et al.
  Pubblicazione: (2026)
• Sick days glycaemic outcomes in a cohort of children and adolescents with type 1 diabetes using an AID system—A preliminary report
  di: Davide Tinti, et al.
  Pubblicazione: (2025)
• Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses
  di: Davide Tinti, et al.
  Pubblicazione: (2025)
• Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery System
  di: Georgia M. Davis, et al.
  Pubblicazione: (2024)
• The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies
  di: Romy Slebe, et al.
  Pubblicazione: (2024)